Kilian B. Kennel
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.
Journal: The Journal of pathology
Published: November 14, 2025
The immune microenvironment of colorectal cancer.
Journal: Nature reviews. Cancer
Published: August 15, 2025
Current and emerging concepts for systemic treatment of metastatic colorectal cancer.
Journal: Gut
Published: March 27, 2025
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 21, 2022
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade.
Journal: Gut
Published: May 21, 2022
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer.
Journal: Cancer cell
Published: September 29, 2021
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
Journal: JCI insight
Published: July 20, 2021
Immune cell - produced ROS and their impact on tumor growth and metastasis.
Journal: Redox biology
Published: December 10, 2020
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.
Journal: Nature
Published: November 25, 2019
Prolyl Hydroxylase Inhibition Mitigates Pouchitis.
Journal: Inflammatory bowel diseases
Published: May 20, 2019
Last Updated: 09/26/2026